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Introduction
Atrial fibrillation (AF) is associated with different
amounts of diffuse fibrosis, which has impact in the
therapy response. CMR is able to assess myocardial
fibrosis using late gadolinium enhancement (LGE) and
chamber function.
Purpose
The aim of this study was to assess, in patients with AF
if the presence and extension of atrial fibrosis was
related with atrial size and function.
Methods
47 (42 male, 42±8 years-old) consecutive patients (pts)
with paroxysmal AF and indication to ablation were
included. Exclusion criteria for CMR: non-sinus rhythm
and general contra-indications. Before ablation all under-
went CMR for left atrial angiography for CARTO map-
ping. Using CMR, the following variables were assessed:
left ventricle (LV) and left atrium (LA) volumes and
ejection fraction (SSFP, short-axis), LV LGE was assessed
as presence and amount (LGE mass/LV mass). LA LGE
location was assigned to 3 atrial walls: anterior, posterior
and septal. The extension was classified in 3 degrees,
according to the number of atrial walls with LGE: 1=one
wall, 2=two walls; 3=three walls. For CMR analysis dedi-
cated software was used (Philips View Forum Release 6.1).
Results
All studies yielded good image quality. LV end-diastolic
volume was 68±5ml/m2 and normal in all; LV ejection
fraction was 58±4%(48-67), normal in all (in 2 borderline);
11 pts showed minimal LV LGE involving one or two seg-
ments with 0.02% of fibrosis mass/LV mass; mean LA
volume was 115±21ml (increased in 45% o patients); mean
LA ejection fraction was 45±11% (reduced in 65%). Type 1
LGE was found in 17 pts, type 2 in 22 and type 3 in 8 pts.
Comparing the groups with the 3 LGE types, pts with type
3 LGE had larger LA volumes and lower ejection fraction
in comparison with type 1 LGE pts (p=0.004 and p=0.001
respectively). No difference was found between
other groups. No relationship was found with LV volumes,
ejection fraction and amount of fibrosis.
Conclusion
In pts with paroxysmal AF pre-ablation, atrial fibrosis as
assessed semi-quantitatively by CMR was associated to
larger left atrial volume and lower ejection fraction,
which are determinant substrates for the outcome.
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